Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Lantis, MD
St. Luke's-Roosevelt Hospital Center
Principal Investigator - Robert Kirsner, MD, PhD
University of Miami
Principal Investigator - Robert Snyder, DPM
Barry University Clinical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Mesa, Arizona, United States
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Carlsbad, California, United States
- Facility name not stated
Castro Valley, California, United States
- Facility name not stated
Fresno, California, United States
- Facility name not stated
Laguna Hills, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Sylmar, California, United States
- Facility name not stated
Hialeah, Florida, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
South Miami, Florida, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Oak Park, Illinois, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
Emerson, New Jersey, United States
- Facility name not stated
Summit, New Jersey, United States
- Facility name not stated
Toms River, New Jersey, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Chapel Hill, North Carolina, United States
- Facility name not stated
Willoughby, Ohio, United States
- Facility name not stated
Wyomissing, Pennsylvania, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Lewisville, Texas, United States
- Facility name not stated
McAllen, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2014
- Primary completion
- 31 May 2016
- Completion
- 30 Jun 2016
- Last update posted
- 23 Sept 2015
- Registered enrollment
- 252
- Registry id
- NCT02130310
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.